MD On-Line's (MDOL) has announced that its ID Recruit, a new tool streamlines clinical trial recruitment, is helping in easy identification of the best candidates for trials in medical research. The identification is based on key criteria ...
Tags: ID Recruit, MDOL
Northwestern's Bluhm Cardiovascular Institute has recently enrolled first patient in ABSORB III, a clinical trial to compare the performance of Abbott's drug eluting Absorb Bioresorbable Vascular Scaffold (BVS) device with other traditional ...
Tags: Absorb device, Medicine
Litera has acquired AxxiTRIALS clinical trials portal solution that enables secure global document sharing and community management tools for life sciences. The solution provides life science companies and clinical research organizations ...
Tags: Litera, Clinical Trials
Sunovion Pharma and San Diego-based drug discovery platform company Afraxis have entered into a partnership agreement to use the unique enhanced spine platform (ESP), to boost Sunovion’s preclinical central nervous system (CNS) drug ...
Tags: Sunovion Pharma, Afraxis
Soft Tissue Regeneration has received a patent number 8,486,143 relating to the L-C Ligament, an investigational device for soft tissue regeneration of the anterior cruciate ligament (ACL) of the knee, from the US Patent and Trademark ...
Hansen Medical has enrolled first patients for ARTISAN-AF clinical trial to evaluate the use of Artisan family of control catheters with its Sensei X robotic catheter system for treatment of atrial fibrillation. The robotic catheter ...
Tags: Hansen Medical, Clinical Trial
The US Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel is scheduled to decide on Ocular Therapeutix’s premarket approval application for the ReSure Sealant in September and may suggest some recommendations. ...
Tags: Ophthalmic Devices, Health
Cerevast Therapeutics has initiated patient enrollment in the Phase III clinical trial to evaluate the use of its Clotbust ER ultrasonic headframe for the treatment of acute ischemic stroke. The Clotbust ER Phase III clinical study is ...
Tags: Cerevast Therapeutics
British drugmaker AstraZeneca and US biotechnology company FibroGen have formed a strategic partnership to develop and commercialize FG-4592 to treat anemia in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). ...
Tags: Anemia Drug, Astrazeneca
OxyBand Technologies has commenced the shipments of its new oxygenated wound dressings that targets oxygen delivery into the wound for faster healing. The US Army Institute of Surgical Research (ISR) at Fort Sam Houston in Texas has ...
EnteroMedics has submitted premarket approval (PMA) application to the US Food and Drug Administration (FDA) for Maestro Rechargeable System's VBLOC, a vagal blocking therapy to treat obesity. Maestro RC system delivers vagal blocking ...
Tags: EnteroMedics, Vbloc Therapy
Japan-based Takeda Pharma has received positive CHMP opinion for its three new type 2 diabetes therapies from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP). The therapies include Vipidia ...
Tags: Therapies, CHMP Opinion
British drug-maker GlaxoSmithKline (GSK) has reached settlement with the attorneys general of eight US states over misleading marketing of the diabetes treatment drug, Avandia, and even agreed to pay $229m to settle the lawsuits. Without ...
Tags: Avandia Lawsuits, Medicine
Contract service organization SGS Life Science Services has selected Merge eClinical OS to optimize data management across Phase I-IV studies. With flexibility to support trials in any phase, capture any type of data, from any source and ...
Tags: SGS, Phase I-IV Studies
Imprimis Pharmaceuticals has received approval from the Institutional Review Board (IRB) to initiate Phase III clinical trial protocol of its new topical non-steroidal anti-inflammatory drug (NSAID) candidate, Impracor. Impracor is based ...